Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,180,266 papers from all fields of science
Search
Sign In
Create Free Account
Hereditary Malignant Neoplasm
Known as:
Familial Cancer
, Familial Malignant Neoplasm
, Hereditary Cancer
Cancer that occurs in families more often than would be expected by chance. These cancers often occur at an early age, and may indicate the presence…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Neoplastic Cell
cancer cell
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
M. Abdel-Rahman
,
R. Pilarski
,
+5 authors
F. Davidorf
Journal of Medical Genetics
2011
Corpus ID: 41450546
Objective To investigate the potential contribution of germline sequence alterations in the BAP1 gene in uveal melanoma (UM…
Expand
Highly Cited
2005
Highly Cited
2005
The general public's information needs and perceptions regarding hereditary cancer: an application of the Integrated Change Model.
H. Vries
,
I. Mesters
,
Hermanna van de Steeg
,
C. Honing
Patient Education and Counseling
2005
Corpus ID: 10839634
Review
2005
Review
2005
Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis
D. Braithwaite
,
J. Emery
,
F. Walter
,
A. Prevost
,
S. Sutton
Familial Cancer
2005
Corpus ID: 7947493
Background: Identification of a genetic basis underlying certain types of cancer has led to an increase in demand for genetic…
Expand
Highly Cited
2001
Highly Cited
2001
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Michael A. Hoffman
,
M. Ohh
,
+4 authors
W. Kaelin
Human Molecular Genetics
2001
Corpus ID: 30872757
von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germ line mutation of the von Hippel-Lindau tumor…
Expand
Highly Cited
1998
Highly Cited
1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T. S. Frank
,
S. Manley
,
+22 authors
Alun Thomas
Journal of Clinical Oncology
1998
Corpus ID: 23646915
PURPOSE Previous studies of mutations in BRCA1 or BRCA2 have used detection methods that may underestimate the actual frequency…
Expand
Review
1997
Review
1997
Human cancer syndromes: clues to the origin and nature of cancer.
E. Fearon
Science
1997
Corpus ID: 29366482
More than 20 different hereditary cancer syndromes have now been defined and attributed to specific germline mutations in various…
Expand
Highly Cited
1997
Highly Cited
1997
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
F. Giardiello
,
J. Brensinger
,
+6 authors
S. Hamilton
New England Journal of Medicine
1997
Corpus ID: 10650341
BACKGROUND The use of commercially available tests for genes linked to familial cancer has aroused concern about the impact of…
Expand
Highly Cited
1996
Highly Cited
1996
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Eamonn R. Maher
,
A. Webster
,
+5 authors
Dr Maher
Journal of Medical Genetics
1996
Corpus ID: 340250
Von Hippel-Lindau disease is an autosomal dominantly inherited familial cancer syndrome predisposing to retinal and central…
Expand
Review
1995
Review
1995
Cell-cycle regulators and cancer.
A. Kamb
Trends in Genetics
1995
Corpus ID: 30876398
Review
1980
Review
1980
Familial carotid body tumors: Case report and epidemiologic review
S. Grufferman
,
M. Gillman
,
L. R. Pasternak
,
C. Peterson
,
W. Young
Cancer
1980
Corpus ID: 26986719
We report on the cases of two sisters with carotid body tumor (CBT) and present a literature review that assembles epidemiologic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE